Hematology NewsEarly-stage HL patients fare well 10 years after lower-intensity regimensMay 5, 2017Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsPembrolizumab advances in relapsed/refractory classic Hodgkin lymphomaMay 2, 2017Hodgkin LymphomaLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology TimesPembrolizumab could change treatment paradigm, team saysApril 30, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesALL, HL guidelines added to radiation therapy resourceApril 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLHodgkin LymphomaAggressive Lymphomas
Hematology TimesSecond cancers take greater toll on younger patientsApril 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCancer risk, burden expected to shift in HIV populationApril 11, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCHMP recommends drug for relapsed/refractory cHLMarch 25, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Hematology TimesMost blood cancer mutations due to DNA replication errorsMarch 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesPreterm births more common in cancer survivorsMarch 24, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeUnavoidable, random DNA replication errors are the most common cancer driversMarch 23, 2017Breast CancerPediatricsPatient & Survivor CareGenitourinary CancerHodgkin LymphomaMantle Cell Lymphoma
Hematology TimesVeterans don’t have higher risk of leukemia, lymphomaMarch 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA approves pembrolizumab to treat cHLMarch 15, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Hematology TimesFamily history impacts risk of second cancer after HLMarch 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesImmunotherapy receives fast track designationFebruary 22, 2017Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesStyrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
